Effect of Anticoagulant Drug Intervention on Postoperative MALE and MACE in Patients With PAD

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

6000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-01-01

Study Completion Date

2026-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients with PAD were grouped according to the combination of different anticoagulant and antiplate drugs. The type, dosage and duration of anticoagulant and antiplatelet drugs were recorded after operation. Major Adverse Cardiovascular Events and Major Adverse Limb Events were followed up at 1 month, 6 months and 12 months, respectively.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of Anticoagulant and Antiplatelet Drug Intervention on Postoperative Major Adverse Events in Patients with PAD：Phase II

NCT06850207

Peripheral Arterial Disease(PAD)

NOT_YET_RECRUITING

Selective Thromboembolism Prophylaxis After Arthroplasty

NCT03804697

Venous Thrombosis, Deep Arthroplasty Complications

COMPLETED NA

Mechanical Thrombectomy for Acute Lower Limb Deep Vein Thrombosis in Tumor Patients

NCT06085495

Cancer Patients With Acute Lower Limb Deep Vein Thrombosis (DVT)

COMPLETED NA

Optimal Duration of Anticoagulation in Deep Venous Thrombosis

NCT01285661

Deep Vein Thrombosis of Lower Limb Lower Extremity Deep Venous Thrombosis Recurrent

COMPLETED PHASE3

Prospective Evaluation of Bleeding Risk of Anticoagulant and Anti-platelet Therapy

NCT00625248

Bleeding

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anticoagulant Drugs Antiplatelet Drug Peripheral Arterial Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Use a combination of anticoagulant or antiplatelet drugs ， group 1

anticoagulant or antiplatelet drugs

Intervention Type DRUG

combination of anticoagulant or antiplatelet drugs

Use a combination of anticoagulant or antiplatelet drugs， group 2

anticoagulant or antiplatelet drugs

Intervention Type DRUG

combination of anticoagulant or antiplatelet drugs

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

anticoagulant or antiplatelet drugs

combination of anticoagulant or antiplatelet drugs

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age ≥50 years old
2. Patients with symptomatic PAD
3. Moderate intermittent claudication, or severe limb ischemia
4. Radiographically confirmed occlusion
5. Received a successful revascularization

Exclusion Criteria

1. Acute limb ischemia occurred within 2 weeks before revascularization;
2. Large tissue defect of any lower limb (defined as obvious ulceration/gangrene near phalangeal head);
3. After revascularization, there are clinical conditions requiring systemic anticoagulation

Minimum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No